Adjunct Hyperbaric Oxygen Therapy in Periorbital Reconstruction

Gonnering, Russell S.; Kindwall, Eric P.; Goldmann, Robert W.

doi:10.1001/archopht.1986.01050150141046

Cited by 16 publications

(6 citation statements)

References 31 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Rather, the only information that is available comes from case reports. In 1986, Gonnering et al 20 described the use of hyperbaric oxygen in six case studies of periorbital reconstructions of which three were larger than normal composite grafts (17 ϫ 5 mm, 20 ϫ 7 mm, 22 ϫ 5 mm). The treatment regimen was 100% oxygen at 2.0 ATA for 2 hours twice per day for 4 to 5 days.…”

Section: S Clinical Studiesmentioning

confidence: 46%

An Evidence-Based Appraisal of the Use of Hyperbaric Oxygen on Flaps and Grafts

Friedman

Fitzmaurice

Lefaivre

et al. 2006

Plastic and Reconstructive Surgery

View full text Add to dashboard Cite

Hyperbaric oxygen has been advocated, both as an adjunctive or primary form of treatment, for a variety of disorders, including gas gangrene, osteoradionecrosis, and carbon monoxide poisoning. It has also been used to improve ischemic wounds before skin grafting and to support ischemic flaps. In this review, we analyze the available literature that investigates the use of hyperbaric oxygen for composite grafts, skin grafts, random flaps, distant flaps, and free flaps. An appraisal of the level of evidence for each of these uses of hyperbaric oxygen is offered. Although there are a significant amount of animal data supporting the application of hyperbaric oxygen for grafts and flaps, there is very little clinical information other than case reports and series to sustain its choice over other modalities of therapy. Multicenter prospective clinical studies are clearly needed comparing hyperbaric oxygen to other mechanical or pharmacologic interventions to improve wound healing for grafting or to support flap survival.

show abstract

Section: S Clinical Studiesmentioning

confidence: 46%

An Evidence-Based Appraisal of the Use of Hyperbaric Oxygen on Flaps and Grafts

Friedman

Fitzmaurice

Lefaivre

et al. 2006

Plastic and Reconstructive Surgery

View full text Add to dashboard Cite

show abstract

“…3 , 8 , 19 The few case reports available have shown high graft survival rates and good cosmetic outcomes. [20][21][22] Nichter et al reported the reattachment of a near-total avulsion of the nose measuring 4 × 3 cm in a 2-year-old patient. With HBO therapy following (19 treatments over 11 days at 2.5 Atm), complete graft survival was achieved.…”

Section: Additional Measuresmentioning

confidence: 99%

Hyperbaric Oxygen Therapy for Large Composite Grafts: An Alternative in Pediatric Facial Reconstruction

Camison

Naran

Lee

et al. 2020

Journal of Plastic, Reconstructive & Aesthetic Surgery

View full text Add to dashboard Cite

“…Composite grafts contain multiple structures, such as cartilage, subcutaneous fat, and skin [42]. Gonnering [45] reports on a case series with 6 subjects who underwent periorbital reconstructions using composite grafts. These grafts were larger than normal composite grafts (eg, 2 by 0.7 cm); all survived.…”

Section: Surgical Reconstruction (Without Flaps or Grafts)mentioning

confidence: 99%

Hyperbaric Oxygen Therapy for Wound Healing and Limb Salvage: A Systematic Review

Goldman

2009

PM&R

127

View full text Add to dashboard Cite

This article is a systematic review evaluating published clinical evidence of the efficacy of hyperbaric oxygen therapy (HBOT) for wound healing and limb salvage. The data source is the Ovid/Medline database for key word "Hyperbaric Oxygenation" with search limits (human studies, 1978-2008). Results were combined by Boolean AND with 1 of the 3 following searches: (a) wound healing (10 permutations); (b) compromised flap or graft (3); and (c) osteomyelitis (1). The author evaluated 620 citations, of which 64 reported original observational studies and randomized controlled trials (RCTs) on HBOT and healing outcomes. All citations with 5 subjects were selected for full text review (44 articles) and evaluated according to GRADE criteria for high, medium, low, or very low level of evidence. A Cochrane review identified 1 additional study with a low level of evidence. This systematic review discusses and tabulates every article of high or moderate level of evidence. For patients with diabetic foot ulcers (DFU) complicated by surgical infection, HBOT reduces chance of amputation (odds ratio [OR] 0.242, 95% CI: 0.137-0.428) (7 studies) and improves chance of healing (OR 9.992, 95% CI: 3.972-25.132) (6 studies). Positive efficacy corresponds to HBOT-induced hyperoxygenation of at-risk tissue (7 studies) as measured by transcutaneous oximetry. HBOT is associated with remission of about 85% of cases of refractory lower extremity osteomyelitis, but an RCT is lacking to clarify extent of effect. There is a high level of evidence that HBOT reduces risk of amputation in the DFU population by promoting partial and full healing of problem wounds. There is a moderate level of evidence that HBOT promotes healing of arterial ulcers, calciphylactic and refractory vasculitic ulcers, as well as refractory osteomyelitis. There is a low to moderate level of evidence that HBOT promotes successful "take" of compromised flaps and grafts.

show abstract

Adjunct Hyperbaric Oxygen Therapy in Periorbital Reconstruction

Cited by 16 publications

References 31 publications

An Evidence-Based Appraisal of the Use of Hyperbaric Oxygen on Flaps and Grafts

An Evidence-Based Appraisal of the Use of Hyperbaric Oxygen on Flaps and Grafts

Hyperbaric Oxygen Therapy for Large Composite Grafts: An Alternative in Pediatric Facial Reconstruction

Hyperbaric Oxygen Therapy for Wound Healing and Limb Salvage: A Systematic Review

Contact Info

Product

Resources

About